Maureen Testoni's Profile Image

Maureen Testoni

Maureen has taken a leave of absence from the firm effective April 1, 2018.

Maureen Testoni has been representing health care providers in law firms, in trade associations, and on Capitol Hill for almost 30 years, providing legal, policy and advocacy counsel.

Maureen is a national expert on all aspects of the 340B program, having spent almost 7 years at 340B Health, the national trade association representing more than 1,300 340B hospitals and health systems. She most recently served as the Senior Vice President and General Counsel at 340B Health, where she oversaw the Legal, Policy, and Government Affairs Division, working to influence law and policy regarding the 340B program. Maureen also regularly provided direct assistance to health systems regarding 340B implementation, compliance, audits and appeals, and federal policy.

Maureen’s work in private practice has included representing — and working with Mike Flanagan in the representation of — hospitals, nursing homes, home health agencies, and other providers of health care services regarding compliance with Medicare and Medicaid reimbursement, fraud and abuse laws, and HIPAA.

In addition to her years of work with 340B Health, Maureen’s significant experience with health care trade associations further includes serving as Senior Director for Legal and Regulatory Affairs at the American Psychological Association. In each trade association role, she advised the associations and their members on legal and advocacy issues.

Maureen also spent several years on Capitol Hill advising members of Congress on health care policy.

Maureen is a member of the D.C. and Virginia bars. She received her law degree from The George Washington University National Law Center, with honors, and her BA in Public Policy from the University of Chicago.

Selected Presentations

  • HRSA 340B Audits: Process and Findings, updated and regularly presented at winter and summer 340B Coalition Conferences, 2014-2017
  • The 340B Drug Pricing Program: Key Challenges and Preparing for the Future, Healthcare Financial Management Association National Institute, June 2016
  • Overview of the 340B Drug Discount Program and Pricing Calculations, Medicaid Drug Rebate Program Summit, September 2016
  • Medicaid: New 340B Models with CMS and OIG Perspectives, 340B Coalition Conference, July 2016
  • Overview of Hospital Participation in the 340B Drug Pricing Program in 2015 – Participation Requirements, Congressional Interest & Federal Oversight, Healthcare Financial Management Association Webinar, April 2015
  • Dissecting the 340B Mega-Guidance (Intermediate), American Health Lawyers Association Webinar, October 2015
  • Making a 340B Compliance Work, 340B Coalition Conference, February 2014
  • The Future of Patient Definition, 340B Coalition Conference, July 2014

Selected Publications

  • Understanding the 340B Audit Process, Pharmacy Purchasing & Products, December 2016
  • A Prescription for Change, Proposed Changes to the 340B Drug Pricing Program, Healthcare Financial Management Magazine, October 2015
  • Drug Discount Analysis Misses the Mark, Health Affairs Blog, October 8, 2014
  • A Legal Perspective on 340B Compliance, Pharmacy Purchasing and Products, July 2014
  • 340B Toolkit, American Health Lawyers Association, June 2014, contributing author

For More Information

  • This field is for validation purposes and should be left unchanged.